Study details
Enrolling now
A Treatment for Age-Related Central Auditory Processing Disorder
University of Colorado, Denver
NCT IDNCT07304024ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1/2
Target enrollment
344
Study length
about 2.6 years
Ages
45–65
Locations
1 site in CO
About this study
This trial is testing a treatment combining Clemastine Fumarate with engineered sound to improve hearing in noisy environments. The goal is to determine if this combination therapy can help people with age-related central auditory processing disorder (CAPD) better hear sounds amidst background noise.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Clemastine Fumarate Combined With Engineered Sound
- 2.Take Clemastine Fumarate Combined With Pink Noise
- 3.Take Placebo - Placebo
- +1 more
PhasePhase 1/Phase 2
DrugClemastine Fumarate Combined
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low11%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
Respiratory System Agent (Histamine H1 Receptor Antagonists)
Drug routes
oral (Oral Tablet)